Skip to content
Search

Latest Stories

‘Pharmacy Inquiry’ pushed back by few weeks, says MP Steve Brine

The Pharmacy Inquiry, which was scheduled to begin this week, has been postponed for a 'couple of weeks' due to the King's Speech

MP Steve Brine, the chair of the health and care committee, said that the healthcare in the UK “doesn’t work without pharmacy”.


The inquiry focuses on addressing current issues, particularly around the “funding model, digital infrastructure and workforce recruitment, training and retention.”

Brine said at the Sigma annual conference on Sunday, that he wants to “focus on the sector”, and “drill down into some of the challenges and potential” that lies ahead.

“The Health and Social Care Committee, we think about much of our work through the lens of pharmacy, what role it plays, the quality of care that it delivers, and the potential for it to do more,” said Brine.

He further said that he wants to “build on the groundwork” and to “cover as many of the different pharmacy services within the pharmacy sector as we can, so pharmacy in our communities, in hospitals and general practice”.

However, the key question that arises here is “What does the future policy look like? What must the government do in the present to ensure that jobs appear to be realised?”

Brine told the attendees at the conference that he aims to keep the committee’s inquiry “on the shoulders of the work that’s been done in the past” on pharmacy.

He said: “You would be forgiven for thinking ‘another inquiry, another report,’ but we are not starting from day one. We stand on the shoulders of the work that’s been done in the past, the work I did in government, and the work Community Pharmacy England and King’s Fund recently did, the brilliant thesis from the University of Bath that Bharat (Sigma's founder) and Sigma which was brought to the House of Commons this summer, we stand on the shoulders of all of that.”

Earlier this year, the Health and Social Care Committee announced it had launched a  pharmacy inquiry into action needed to ensure community pharmacies are “in the best shape” to meet demands and take advantage of future opportunities.

The inquiry explores “issues impacting different types of pharmacy, with a particular focus on community, primary care and hospital pharmacy services”.

The idea is to implement a 'Pharmacy First' strategy that will see community pharmacists commissioned with more services such as contraception and hypertension, so patients receive professional healthcare advice, treatments, and medicines for common illnesses without the need for an appointment.

Brine confirmed the inquiry’s first session will be "very soon" which will be an “opportunity” for witnesses, and to give “instructions for challenges and opportunity for the sector.”

As stated, it will be a “live piece of work” for everyone to make “suggestions as to who we might talk to.”

He said: “It is there for you to make suggestions for yourself to be guests on the TV show. That's how I consider this a select committee.”

Moreover, he also said that he wants to “cover key issues” and his committee will “come up with solutions or recommendations” that will “inform the next government whatever colour that is as much as it will the current government.”

Brine's committee is currently in the midst of a significant inquiry on prevention and healthcare which prominently features pharmacy.

He added: “We've already done the vaccination work stream, the health of places where we live, where we work and how they impact other determinants of poor health.

“We're now moving on to addictions, so alcohol and smoking. And then we're going to do sexual health as the fourth workstream.”

Moreover, he praised PM Rishi Sunak’s bold step to put a ban on smoking which will “save millions of lives”.

In conclusion, he stressed the select committee's dedication to prioritising the pharmacy sector over the next 12 months and keeping their work at the forefront.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less